Navigation Links
Tissue Bank Makes it Easier for Injured Servicemen and Women
Date:5/29/2008

EDISON, N.J., May 29 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF) will provide military hospitals with special access to tissue needed for cartilage and joint repair for injured servicemen and women.

Military hospitals and facilities will be given priority in obtaining tissue used for cartilage transplantation and meniscus grafts used for joint repair. Already in short supply, these types of tissue are in high demand for U.S. servicemen and women, many of whom have undergone traumatic injury to the cartilage of the knee, ankle or elbow in the course of their duties.

"MTF is proud to assist our servicemen and servicewomen by addressing the needs of military hospitals for specialized allograft tissues that are useful in repairing damaged knee and ankle joints," said Bruce Stroever, MTF President and CEO. "MTF will provide priority access to military hospitals for these grafts which are very difficult to obtain. Our military personnel do so much for our country; it's a pleasure and an honor for us to be able to help them receive the best surgical care possible when the need arises."

MTF, the largest tissue bank in the nation, is a non-profit service organization dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families.

For more information, contact Melinda Lockard, at 651-675-4210, or Melinda_Lockard@mtf.org.


'/>"/>
SOURCE Musculoskeletal Transplant Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Heterotopic gastric tissue simulating acute appendicitis
2. Do It Now College Program Registers Nearly 125,000 New Organ and Tissue Donors
3. Acne Drug Prevents Tissue Damage From Emphysema
4. 2nd ESMO symposium on soft tissue carcinomas and GIST
5. How embryonic stem cells develop into tissue-specific cells demonstrated
6. Three Million Californians Say Yes! to Organ and Tissue Donation
7. Congressional Organ and Tissue Donation Awareness Caucus Hosted Congressional Staff Meeting on April 29 to Spread the Truth About Organ Donation
8. Stored Ovarian Tissue Needs Testing Before Re-Implantation
9. Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
10. New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries
11. Houston-Based LifeGift Becomes States Only Stand-Alone Organ and Tissue Recovery Agency
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:The Female Health Company Schedules First Quarter Conference Call for February 13, 2008 2Health News:Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Vitals.com 'Goes Red' for American Heart Month 2Health News:Vitals.com 'Goes Red' for American Heart Month 3Health News:Bonn scientists simulate dinosaur digestion in the lab 2Health News:Bonn scientists simulate dinosaur digestion in the lab 3Health News:Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses 2Health News:Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses 3Health News:CVS Samaritan Van Program Celebrates 30 Years of Helping Motorists on the Nation's Highways 2Health News:CVS Samaritan Van Program Celebrates 30 Years of Helping Motorists on the Nation's Highways 3Health News:CVS Samaritan Van Program Celebrates 30 Years of Helping Motorists on the Nation's Highways 4
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Its Better to Give Than to Receive 55771 1Its Better to Give Than to Receive 55771 2Its Better to Give Than to Receive 55771 3Change in Seasons 3A Ideal Time to Review Healthy Aging Habits 55768 1Change in Seasons 3A Ideal Time to Review Healthy Aging Habits 55768 2Prostate Cancer Over Diagnosed 3A Study 55767 1Prostate Cancer Over Diagnosed 3A Study 55767 2Prostate Cancer Over Diagnosed 3A Study 55767 3